Title:  Postdoctoral Associate

Division:  Pediatrics
Schedule:  M-F 8-5
Work Location:  Texas Medical Center, Houston, TX
Salary Range:  $50,004 - $54,756
FLSA Status:  Exempt
Requisition ID:  430
Summary

The position is to develop the next-generation immunotherapy for cancer in the translational laboratory of dr. Andras Heczey.  The lab has a strong focus on using CAR T cells and CAR NKT cells with outstanding track record of preclinical research and translation to early phase clinical trials.  The laboratory is funded by multiple large grants (including form the Cancer Prevention and Research Institute of Texas, the American Cancer Society, the V Foundation, the Alex's Lemonade Foundation) and has established strong sponsored industrial research agreement with a commercial partner.  The stimulating scientific environment and mentorship provides an ideal place for driven scientists to succeed.

For more information about the lab and PI, please visit: https://www.texaschildrens.org/find-a-doctor/andras-heczey-md

Job Responsibilties

The position focuses on genetic engineering strategies to redirect the immune cells to attack cancer cells and the post-doctoral associate will be working in the combined translational laboratories of the Texas Children's Cancer Center and the Center for Cell and Gene Therapy of Baylor College of Medicine.

 

It is essential that the applicant is knowledgeable in fields relevant to immunology (including ex vivo culture of lymphocytes, multiparametric flow cytometry, cytotoxicity assays etc), tumor immunology and has sufficient understanding of viral non-viral vectors. The candidate should be comfortable working with mice. 

Minimum Qualifications

Education: Ph.D in basic or translational science

Experience:

  • Understanding basic tumor immunology principles
  • Understanding basic genetic engineering techniques (transfection, retroviral / lentiviral transduction)

 

 

 

 

Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer.

 430

CA; CH; PD